SEC Form 4 · accession 0001140361-15-044902
Emergent BioSolutions Inc. · EBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Abdun-Nabi
Officer — President & CEO · Director
Period of report
Dec 15, 2015
Accepted (ET)
Dec 17, 2015 · 3:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 15, 2015 | M | 4,140 | $24.15 | A | 188,009 | D | |
| Common StockF1 | Dec 15, 2015 | F | 2,641 | $37.87 | D | 185,368 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1,F2 | $24.15 | Dec 15, 2015 | M | 4,140 | D | Mar 15, 2012 | Mar 14, 2018 | Common Stock | 4,140 | 37,860 | D |
Explanation of responses
- F1Consists of options granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan.
- F2The option vested in three equal installments in March 2012, 2013 and 2014.